Timothy J. Whelan

Active 1994–2025

115
Papers
42,337
Citations
81
h-index
114
i10-index

Citations

Citations per year for Timothy J. Whelan1974: 1 citations1980: 7 citations1981: 1 citations1995: 1 citations1996: 3 citations1997: 7 citations1998: 19 citations1999: 45 citations2000: 31 citations2001: 79 citations2002: 76 citations2003: 136 citations2004: 150 citations2005: 199 citations2006: 226 citations2007: 214 citations2008: 232 citations2009: 198 citations2010: 208 citations2011: 181 citations2012: 198 citations2013: 240 citations2014: 232 citations2015: 196 citations2016: 283 citations2017: 300 citations2018: 273 citations2019: 1,165 citations2020: 1,298 citations2021: 1,087 citations2022: 779 citations2023: 561 citations2024: 980 citations2025: 349 citations2026: 15 citations1975–1979: no citations, so these years are not shown1982–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,275 citing papers, 25.7% of this breakdownUnited Kingdom: 1,040 citing papers, 8.1% of this breakdownCanada: 857 citing papers, 6.7% of this breakdownChina: 736 citing papers, 5.8% of this breakdownGermany: 671 citing papers, 5.3% of this breakdownItaly: 654 citing papers, 5.1% of this breakdownNetherlands: 527 citing papers, 4.1% of this breakdownAustralia: 463 citing papers, 3.6% of this breakdownFrance: 363 citing papers, 2.8% of this breakdownSwitzerland: 346 citing papers, 2.7% of this breakdownBelgium: 283 citing papers, 2.2% of this breakdownSpain: 276 citing papers, 2.2% of this breakdown
0%25.7%Other 25.7%

Fields

  • Medicine39%
  • Biochemistry, Genetics and Molecular Biology36.5%
  • Health Professions15.7%
  • Computer Science1.8%
  • Physics and Astronomy1.4%
  • Psychology0.8%
  • Other4.8%

Topics

  • Breast Cancer Treatment Studies12%
  • Patient-Provider Communication in Healthcare5.5%
  • Breast Lesions and Carcinomas4.2%
  • Breast Implant and Reconstruction2.8%
  • HER2/EGFR in Cancer Research2.4%
  • Cancer survivorship and care2%
  • Other71.1%

Coauthors

All papers

Open in search
  1. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 2,369

  2. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

    Authors: , , , , , , , , , , , , , , - The Lancet 2011 cited by 3,940

  3. Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)

    Authors: , , - Social Science & Medicine 1997 cited by 4,130

  4. Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2022 cited by 223

  5. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 cited by 1,837

  6. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chiun‐Sheng Huang, Jens Huober, Hussein Khaled, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, Kent C. Osborne, Olivia Pagani, Ann H. Partridge, K. Pritchard, Jungsil Ro, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Toru Watanabe, Timothy J. Whelan, Binghe Xu - Annals of Oncology 2017 cited by 1,255

  7. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jon Godwin, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Ewan Straiton, Yaochen Wang, John Crown, Evandro de Azambuja, Suzette Delaloge, Helena Fung, Charles E. Geyer, M. Spielmann, Pinuccia Valagussa, Kathy S. Albain, Stewart Anderson, R. Arriagada, John Bartlett, Elizabeth Bergsten-Nordström, Judith M. Bliss, Étienne Brain, Lisa Carey, Robert E. Coleman, Jack Cuzick, Nancy E. Davidson, Lucia Del Mastro, Angelo Di Leo, James J. Dignam, Mitch Dowsett, Bent Ejlertsen, Prue Francis, Michael Gnant, Matthew Bidwell Goetz, Pam Goodwin, Pat Halpin-Murphy, Daniel Hayes, Catherine Hill, Reshma Jagsi, Wolfgang Janni, Sibylle Loibl, Eleftherios P. Mamounas, Miguel Martín, Hirofumi Mukai, Valentina Nekljudova, Larry Norton, Yasuo Ohashi, Lori J. Pierce, Philip Poortmans, Vinod Raina, Daniel Rea, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Tanja Španić, Joseph A. Sparano, Guenther G. Steger, Gong Tang, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Xiang Wang, Timothy J. Whelan, Nicholas Wilcken, Norman Wolmark, David Cameron, Jonas Bergh, Kathleen I. Pritchard and 1 more - The Lancet Oncology 2021 cited by 348

  8. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christina Davies, Frances Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert K. Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter A. Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther G. Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, J.-M. Nogaret, C. Philippson, Martine Piccart, Sabine C. Linn, Petronella G.M. Peer, Vivianne C. G. Tjan‐Heijnen, S.B. Vliek, John R. Mackey, Dennis Slamon, John M.S. Bartlett, Vivien Bramwell, Bingshu E. Chen, Stephen Chia, Karen A. Gelmon, Paul E. Goss, Mark N. Levine, Wendy R. Parulekar, Joseph L. Pater, Eileen Rakovitch, Lois E. Shepherd, Dongsheng Tu, Timothy J. Whelan, Donald A. Berry, Gloria Broadwater, Constance Cirrincione, Hyman B. Muss, Raymond L. Weiss, Yi Shan, Yong fu Shao, Xiang Wang, Binghe Xu, Dongbing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fátima Cardoso, Tanja Čufer, Jean‐Pierre Julien, Philip Poortmans, Emiel J. Rutgers, Cornelis J.�H. van de Velde, Eva Carrasco, Miguel Ángel Seguí, Jens‐Uwe Blohmer, Serban Dan Costa, Bernd Gerber and 67 more - The Lancet 2019 cited by 394

  9. Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 786

  10. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 1,867

  11. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 555

  12. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George W. Sledge - New England Journal of Medicine 2015 cited by 1,439

  13. Decision-making in the physician–patient encounter: revisiting the shared treatment decision-making model

    Authors: , , - Social Science & Medicine 1999 cited by 2,342

  14. Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 170

  15. Regional Nodal Irradiation in Early-Stage Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 1,296

  16. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline

    Authors: , , , , , , , , , , , , , , , - Practical Radiation Oncology 2018 cited by 606

  17. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 648

  18. Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study

    Authors: , , , , , , , , , , - BMJ 2023 cited by 132

  19. Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , - Practical Radiation Oncology 2023 cited by 170

  20. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. Frank Wilson, Islam Mohamed, Caroline Holloway, Ken Mills, David Petrik, Juanita Crook, Frances Wong, Hannah Carolan, D. Voduc, Paris‐Ann Ingledew, Sonia Nguyen, Mira Keyes, Lorna Weir, Scott Tyldesley, Peter Lim, Christina Parsons, Robert Olson, Paul Blood, Elaine S. Wai, Pauline T. Truong, Hosam A. Kader, Abraham Alexander, Aminudin R. Mydin, Sally Smith, María T. Vlachaki, Valérie Panet-Raymond, Krystine Lupe, Jennifer Goulart, David H. Nguyen, Karen Chu, Joycelin Canavan, Julianna Caon, Susan A. Tyler, Negin Shahid, Jacqueline Lam, John Amanie, Diane Severin, Bassam Abdul Karim, Keith Tankel, Nadeem Pervez, Kurian Joseph, Zsolt Gabos, Barbara Krause, Fleur Huang, Tien Phan, Peter Craighead, Elizabeth Yan, Jill MacKinnon, Robert Nordal, Siraj Husain, Jon-Paul Voroney, Richie Sinha, James Pinilla, Andrew Cooke, Kalyani Vijayraghavan, Steven Latosinsky, Elizabeth Saettler, Yiu-Keung Lau, Marianne Krahn, Ethel MacIntosh, Maged N. F. Nashed, Bashir Bashir, Vamsee Torri, Benjamin A. Goldenberg, Christina Kim, V. Basrur, Ramana Rachakonda, Darin Gopaul, Sundeep Shahi, Sofya Kobeleva and 170 more - The Lancet 2019 cited by 424

  21. Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 cited by 114

  22. Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2022 cited by 107

  23. Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 101

  24. Claudin-Low Breast Cancer; Clinical & Pathological Characteristics

    Authors: , , , , , , , , - PLoS ONE 2017 cited by 162